Abstract. Head and neck squamous cell carcinoma is a complex disease with several etiologic factors and different molecular changes that may trigger certain events; it is also globally one of the most common malignancies in this topography. Extracts from Viscum album L. (VA) (mistletoe) have been used as adjuvant therapies with promising results in several types of cancer, mainly in European countries. In vitro studies have demonstrated that various types of VA may have cytotoxicity in carcinoma cells, activating the apoptotic cascade or leading cells to necrosis. This study aimed to verify the effects of three types of VA extracts (Iscador Qu Spezial, Iscador P and Iscador M) in squamous cell carcinoma of the tongue cell lines SCC9 and SCC25, not previously studied. A concentration of 0.3 mg/ml (IC 50 ) of the drugs induced apoptosis, affecting gene expression and protein levels of AKT, PTEN and CYCLIN D1. It was concluded that VA extracts have a cytotoxic effect on SCC9 and SCC25 cell lines, but while SCC9 cell line was more resistant to the action of the drugs, Iscador Qu Spezial and Iscador M have higher cytotoxic potential in both cell lines compared to Iscador P.
Introduction
Head and neck squamous cell carcinoma is the sixth most frequent neoplasm worldwide (1, 2) . Even with advances in adjuvant therapies, survival rates have not improved significantly over the last 20 years (3). The major risk factors are tobacco and alcohol (4) , but some reports also suggest human papilloma virus infections (5) . Surgical excision, radiotherapy or a combination of both are the treatments of choice (6, 7) . Chemotherapy is occasionally used (6, 7) . Although a combination of treatments has proven efficient, the toxicity levels are high (8, 9) .
Carcinogenesis is a multifactorial process involving several molecular events. Deregulation of cell cycle-related genes, such as AKT, PTEN and CYCLINs, are common among these events. AKT is a serine/threonine kinase whose activation is highly correlated with several solid and hematologic types of cancer (10) (11) (12) ; PTEN acts at the G1 phase blocking the cell cycle that suppresses tumour progression (13) (14) (15) . CYCLINs are also essential for the correct cell cycle transition (16, 17) . These genes have been associated with head and neck squamous cell carcinomas.
Viscum album L. (VA), also called mistletoe, is a hemi-parasitic plant, originally found in Europe. Composed of the total plant extract, it implies a composition of great complexity (18) and is found to have a broad application in adjuvant therapy. Available clinical evidence supporting anticancer effects and in vitro studies using cancer cell lines have demonstrated cytotoxic effects that might trigger apoptotic signals (18) (19) (20) (21) (22) (23) . Over 200 host species are known, and it seems that distinct chemical properties of VA are associated with the host (18, 22) . The main components of the plant extract presenting therapeutic application seem to be lectin, viscotoxins and polysaccharides (20) .
Since there are no reports to date on the effect of this plant extract on oral squamous cell carcinomas, responses to different commercially available VA formulas were evaluated in cell lines derived from this cancer type. Results were assessed in terms of cell growth, apoptosis and expression of AKT, PTEN and CYCLIN D1. IC 50 determination using MTS assay. Both cell lines were incubated in 96-well plates (3x10 3 /well) in the presence of different concentrations of Iscador Qu Spezial. After 24, 48 and 72 h of cell culture, cell viability was assessed using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay kit (CellTiter 96 Aqueous One Solution; Promega) at an absorbance of 490 nm using a spectrophotometer. Considering that the amount of the active principle of Iscador Qu Spezial is the same as the Iscador M (5 mg/ml), and half of the Iscador P (10 mg/ml), IC 50 obtained for Iscador Qu Spezial was used to adjust drug volumes accordingly at the time of the experiments.
Materials and methods

Cell
Flow cytometric analysis of apoptosis. Apoptosis was assayed using an Annexin V-FITC/PI Apoptosis Detection kit (BD Pharmingen, Franklin Lakes, NJ, USA) following the manufacturer's protocol. The results were analysed using flow cytometry (BD FACSAria) with BD FACSDiva software, version 6.1.3.U, in order to distinguish viable, early apoptotic, late apoptotic or dead cells.
Relative quantification of gene expression using real-time PCR (qPCR).
The qPCR was performed to determine the expression level of genes: AKT1, AKT2, PTEN and CYCLIN D1. GAPDH was used as internal control. Primer sequences are shown in Table I . Total RNA was extracted from cell lines using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Samples of RNA (1.0 µg) were reverse transcribed with MultiScribe™ (High Capacity cDNA Archive kit; Applied Biosystems, Foster City, CA, USA), according to the manufacturer's protocol. qRT-PCR was carried out using SYBR-Green PCR Master mix (Applied Biosystems) for 10 min at 95˚C, followed by 40 cycles at 95˚C for 10 sec and 60˚C for 1 min. Dissociation curve analyses were performed at the end of cycling. Gene expression was calculated using a relative expression software tool (REST method, Pfaffl 2001).
Western blotting. Ten micrograms of protein were boiled (5 min) and subjected to SDS-PAGE. Western blotting was performed according to a standard protocol using anti-human pAKT (1:700), PTEN (1:100) and CYCLIN D1 (1:75) followed by incubation with secondary antibody (goat anti-rabbit or goat anti-mouse, 1:3,000, respectively). Mouse monoclonal anti-β-actin (1:5,000) was the loading control. The bound antibodies were detected by colorimetric detection kit Opti-4CN.
Immunofluorescence assay. Cells in the cover slip were fixed with methanol, saturated in PBS/3% bovine serum albumin and incubated (1 h) with anti-human pAKT (1:50), PTEN (1:50) and CYCLIN D1 (1:100). Afterwards, washing cells were incubated (45 min) with a secondary antibody (1:50) conjugated with fluorescein, at room temperature in a dark chamber. Three random visual fields (magnification, x400) were observed under a fluorescent microscope, Zeiss Axiophot II (Carl Zeiss, Oberkochen, Germany).
Statistical analysis.
A Mann-Whitney test was used to determine the IC 50 and in the apoptosis assay. The qRT-PCR analysed the drug effect over the gene expression after set time intervals. Data analyses were performed using Statistical Package for Social Sciences (SPSS), version 17.0. P-values ≤0.05 were considered statistically significant.
Results
Iscador Qu Spezial induces cell death dose-and time-dependently.
To determine whether the VA is capable of inducing cell death, both cell lines were treated with Iscador Qu Spezial for 24, 48 and 72 h at various concentrations. The cell viability using MTS showed the time-dependent action of this drug. The determined IC 50 was 0.3 mg/ml after 48 h of exposure (P=0.011) (Fig. 1) . We then used the same concentration (0.3 mg/ml) for assays using Iscador M and Iscador P.
Iscador Qu Spezial and Iscador M are more efficient than Iscador P in inducing cell death in SCC9 and SCC25. To confirm the apoptotic effect of Iscador Qu Spezial, Iscador P and Iscador M in SCC9 and SCC25 cell lines, a flow cytometric assay was performed. Iscador Qu Spezial and Iscador M presented better apoptotic effect in both lineages after 48 h, as compared to Iscador P (Fig. 2) . The results also corroborate the time-dependent action of these drugs since we observed more apoptosis after 48 h than at 24 h of drug exposure.
VA treatment alters the expression of AKT, PTEN and CYCLIN D1 in SCC9 and SCC25.
Real-time PCR was used in order to investigate the impact of the drugs on the relative (Fig. 3) .
Primers (5'→3') --------------------------------------------------------------------------------------------------------------------------------------------------------
Iscador Qu Spezial and Iscador M decreased the protein levels of CYCLIN D1 and pAKT. After 48 h of exposure to
Iscador Qu and Iscador M, but not with Iscador P, the expression of pAKT showed a slight decrease in both cell lines (Fig. 4) , while PTEN levels decreased only in SCC9, upon treatment with Iscador Qu Spezial. CYCLIN D1 protein levels did not vary when cells were treated with Iscador P whereas Iscador Qu Spezial and Iscador M treatment lead to a substantial decrease in the expression levels of CYCLIN D1 (Fig. 4) .
The cell compartment localization of AKT, PTEN and CYCLIN D1 changed after VA treatment. The localization of the proteins pAKT, PTEN and CYCLIN D1 in SCC9 and SCC25 cells upon VA treatment was assessed by immunofluorescence assay. pAKT expression in the nucleus was present in both cell lines regardless of the VA treatment (Fig. 5) .
However, SCC9 cells treated with Iscador P and Iscador M for 48 h also showed a cytoplasmic pattern of staining. The presence of pAKT in the cytoplasm of SCC25 cells was seen only when they were treated with Iscador Qu Spezial (Fig. 5F , J and N). PTEN showed a predominantly nuclear pattern of staining after 24 h of treatment. At 48 h, a cytoplasmic staining could be seen for both lineages at all instances, while nuclear staining disappeared for SCC9 control cells (Fig. 6B) .
CYCLIN D1 location and pattern of expression was independent from the treatment or cell line at 24 h. Cytoplasmic staining was seen after 48 h of treatment, except in SCC9 treated with Iscador Qu Spezial (Fig. 7E and F) .
Discussion
In vitro action of mistletoe extract Iscador (Qu Spezial, Iscador P and Iscador M) was evaluated on cells of tongue squamous cell carcinoma. The viability test showed a time-dependent action of the drug. In agreement, an ampoule of these drugs is used twice or three times a week in cancer treatment (24) . The drug effect was different depending on the cell analysed, as previously observed by other authors (18,19) .
Eggenschwiler et al (22) observed that cell lines derived from the same type of tumor might have distinct behaviors in response to the same drug. In fact, SCC9 cells seem to be more resistant to apoptosis induced by mistletoe when compared with SCC25. On the other hand, Iscador Qu Spezial, because of its higher concentration of viscotoxins and lectins, provided a stronger effect compared with the other extracts, as previously described (18, 20, 22, 23, 25) . We chose to analyse the effect of mistletoe on members of a pathway frequently deregulated in oral squamous cell carcinoma, AKT, PTEN and CYCLIN D1 (15, 26, 27) . Gene expression analysis by qRT-PCR of AKT1, AKT2, PTEN and CYCLIN D1 was not consistent nor in agreement with their respective protein levels. These results suggest that mistletoe role on cell survival is not clearly related to the regulation of this pathway at the gene expression level.
Nevertheless, Iscador Qu Spezial and Iscador M decreased pAKT and CYCLIN D1 protein levels, leading to greater potential to cause cellular death as previously described (18, 22, 23, 25) . The apoptosis triggered by the cytotoxic effects of these drugs may have been caused by inhibition of other signalling pathways also altered in cancers, such as EGFR/Ras/Raf/MEK/ERK (28) . It may also have been triggered by the complex of STAT3 with NF-κB, which can lead to even more significant proliferative potential, through the expression of genes, such as c-myc and CYCLIN D1 (29) . Studies of Sauter et al demonstrated that silencing of CYCLIN D1 also has an effect on inducing apoptosis in several cell lines of squamous cell carcinoma of the head and neck as well as skin and cervix (30) . Baldin et al explain that CYCLIN D1 is detected in the nucleus during cell cycling; however, when cells enter the S phase, the expression increase in cytoplasm and decrease in nucleus (31) . This could clarify the changes in cell locations observed in this study. Under normal conditions, CYCLIN D1 has nuclear localization in G1 and is phosphorylated, ubiquitinized and transported to the cytoplasm in the S phase (29, 31) . The alteration of chromatin structure can explain the agglutinated aspect, which maintains the transcriptional repression of genes in S during early G1. These promoters are accessible only in the transition phase G1/S (31). pAKT acts directly on cell cycle progression, survival and proliferation (28, 32, 33) . The immunofluorescence analyses showed AKT at different cell locations. After AKT activation (pAKT) in the cytoplasm, it can be translocated to the nucleus. However, nuclear pAKT substrates have not been elucidated yet (34, 35) . PTEN immunolocalization was detected after incubation with the drugs, although the quantitative analyses by western blotting were not able to demonstrate this positivity. Nuclear PTEN is involved with maintaining chromosome integrity and DNA repair (36, 37) . A hypothetical action of the drugs analysed here could be the maintenance of nuclear PTEN, because it is protected from degradation by cytoplasmic proteasome. In the nucleus, it is still able to antagonize AKT and provoke apoptosis (37) . A theory claims that translocation of PTEN from nucleus to cytoplasm may be associated with malignancy (38, 39) . In the cytoplasm PTEN acts as a tumor suppressor by blocking PI3K (40) .
This study highlights the fact that Iscador Qu Spezial and Iscador M are able to induce apoptosis in SCC9 and SCC25 cell lines, while Iscador P was less efficient in both lineages. Although the inhibition of CYCLIN D1 and pAKT were detected at the protein level, and a possible effect on protein location within the cell was detected, the nature of the cytotoxicity remains to be identified. SCC9 cells seem to be more resistant to apoptosis induced by mistletoe when compared with SCC25 cells. Our results corroborate previously described effects of VA and suggest that it could be potentially used as a drug in OSCC therapy attempting to reverse a poor prognosis, leading to a better management of the disease.
